These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. Kosugi M, Miyajima A, Kikuchi E, Horiguchi Y, Murai M. Clin Cancer Res; 2006 May 01; 12(9):2888-93. PubMed ID: 16675585 [Abstract] [Full Text] [Related]
4. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, Kikkawa F. Clin Cancer Res; 2005 Apr 01; 11(7):2686-94. PubMed ID: 15814650 [Abstract] [Full Text] [Related]
5. Antimetastatic activity of honokiol in osteosarcoma. Steinmann P, Walters DK, Arlt MJ, Banke IJ, Ziegler U, Langsam B, Arbiser J, Muff R, Born W, Fuchs B. Cancer; 2012 Apr 15; 118(8):2117-27. PubMed ID: 21935912 [Abstract] [Full Text] [Related]
6. Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Miyajima A, Kosaka T, Asano T, Asano T, Seta K, Kawai T, Hayakawa M. Cancer Res; 2002 Aug 01; 62(15):4176-9. PubMed ID: 12154013 [Abstract] [Full Text] [Related]
7. Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model. Hara K, Kusuzaki K, Takeshita H, Kuzuhara A, Tsuji Y, Ashihara T, Hirasawa Y. Anticancer Res; 2001 Aug 01; 21(1A):321-4. PubMed ID: 11299756 [Abstract] [Full Text] [Related]
9. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, Ohigashi T, Asano T, Sakamoto M, Okita H, Murai M, Hayakawa M. Prostate; 2007 Jan 01; 67(1):41-9. PubMed ID: 17044086 [Abstract] [Full Text] [Related]
15. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. de Nigris F, Rossiello R, Schiano C, Arra C, Williams-Ignarro S, Barbieri A, Lanza A, Balestrieri A, Giuliano MT, Ignarro LJ, Napoli C. Cancer Res; 2008 Mar 15; 68(6):1797-808. PubMed ID: 18339860 [Abstract] [Full Text] [Related]
16. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, Bucana CD, Gallick GE, Nickols MA, Westlin WF, Ellis LM. Cancer Res; 2003 May 01; 63(9):2079-87. PubMed ID: 12727823 [Abstract] [Full Text] [Related]
17. Dendritic cell immunotherapy is effective for lung metastasis from murine osteosarcoma. Joyama S, Naka N, Tsukamoto Y, Yoshikawa H, Itoh K. Clin Orthop Relat Res; 2006 Dec 01; 453():318-27. PubMed ID: 16906102 [No Abstract] [Full Text] [Related]
18. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma. Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ. J Am Coll Surg; 2007 May 01; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528 [Abstract] [Full Text] [Related]
19. A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcoma. Wang LF, Zhou Y, Xu YM, Qiu XC, Zhou BG, Wang F, Long H, Chen X, Yang TT, Ma BA, Fan QY, Yang AG. Cancer Invest; 2009 Aug 01; 27(7):774-80. PubMed ID: 19488908 [Abstract] [Full Text] [Related]
20. Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy. Tanaka T, Yui Y, Naka N, Wakamatsu T, Yoshioka K, Araki N, Yoshikawa H, Itoh K. Clin Exp Metastasis; 2013 Apr 01; 30(4):369-79. PubMed ID: 23076771 [Abstract] [Full Text] [Related] Page: [Next] [New Search]